On May 8, 2025, the Food and Drug Administration approved the use of avutometinib and defactinib (Avmapki Fakzynja Co-pack, Verastem, Inc.) for adults with KRAS-mutated recurrent low-grade serous ovar...
ovarian-cancer-treatment
Germ Cell Ovarian Cancer Treatment
Germ cell ovarian cancer is a very rare form of ovarian cancer that develops from the reproductive cells (germ cells) of the ovary. Although it only makes up around...
ovarian-cancer-treatment
Ovarian Cancer Treatment
Ovarian cancer is among the most prevalent gynecologic cancers, which tend to be diagnosed in advanced stages because of its nonspecific symptoms. Early detection and newer t...
ovarian-cancer-treatment